Literature DB >> 29288662

Autophagy dysregulation caused by ApoM deficiency plays an important role in liver lipid metabolic disorder.

Xiao Zhang1, Puhong Zhang2, Jialin Gao3, Qiang Huang4.   

Abstract

Autophagy is thought to be a key mechanism in maintaining the balance of liver lipid metabolism. However, the relationship between apolipoprotein M (ApoM) and autophagy has not been reported, and the role of ApoM in triglyceride metabolism is still unclear. In this study, we investigated the correlation between ApoM and autophagy and liver triglyceride metabolism in ApoM-knockout animal and cellular models. First, we observed that spontaneous hepatic steatosis developed in the liver of adult ApoM-/- mice, which was presented as the accumulation of large quantities of lipid droplets in hepatocytes under electron microscopy; Oil Red O staining showed significant accumulation of triglycerides. At the molecular level, the expression of lipid synthesis-associated proteins (primarily triglyceride synthesis) as well as acetyl-CoA carboxylase alpha (ACACA), fatty acid synthase (FASN) and sterol regulatory element-binding protein 1 (SREBP1) was upregulated. Moreover, lipid metabolic disorder and accumulation were accompanied by dysfunction in autophagy, which displayed predominantly as inhibition of the degradation pathway; for example, P62 protein accumulated and key proteins involved in the initiation of autophagy including ATG7, ATG5-12, Beclin1 and the LC3BII/LC3BI ratio were upregulated as a feedback response. When the autophagy dysfunction was ameliorated by the activation of autophagy pathways induced by starvation, the lipid metabolic disorder was corrected to a certain extent. This suggests that the autophagy dysfunction caused by the deficiency of ApoM is an important factor in hepatic steatosis (triglyceride accumulation). ApoM plays a key role in normal autophagy activity in the liver and thereby further regulates the metabolism of liver lipids, particularly triglycerides.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Apolipoprotein M; Autophagy; Knockout; Triglyceride

Mesh:

Substances:

Year:  2017        PMID: 29288662     DOI: 10.1016/j.bbrc.2017.12.148

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  ApoM regulates PFKL through the transcription factor SREBF1 to inhibit the proliferation, migration and metastasis of liver cancer cells.

Authors:  Xiao Zhang; Yaping Bai; Wenhao Zhu; Xinyue Lv; Wenjun Pei
Journal:  Oncol Lett       Date:  2022-05-16       Impact factor: 3.111

2.  [Crocetin promotes autophagy in injured rat hepatocytes induced by lipopolysaccharide and D-galactosamine in vitro].

Authors:  Hongxing Guo; Ke Gao; Xingjian Zou; Qingwen Deng; Mengxue Chen; Faquan Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-08-30

3.  Non-alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of Collaborative Cross mice fed an obesogenic high-fat and high-sucrose diet.

Authors:  Volodymyr P Tryndyak; Rose A Willett; Mark I Avigan; Arun J Sanyal; Frederick A Beland; Ivan Rusyn; Igor P Pogribny
Journal:  Epigenetics       Date:  2022-03-24       Impact factor: 4.861

4.  Apolipoprotein M and Sphingosine-1-Phosphate: A Potentially Antidiabetic Tandem Carried by HDL.

Authors:  Mustafa Yalcinkaya; Arnold von Eckardstein
Journal:  Diabetes       Date:  2020-05       Impact factor: 9.461

5.  ApoM is an important potential protective factor in the pathogenesis of primary liver cancer.

Authors:  Yaping Bai; Wenjun Pei; Xiao Zhang; Huihao Zheng; Changchun Hua; Jiao Min; Lisheng Hu; Shuangqiu Du; Zuyue Gong; Jialin Gao; Yao Zhang
Journal:  J Cancer       Date:  2021-06-04       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.